Home » Stocks » PRPO

Precipio, Inc. (PRPO)

Stock Price: $2.25 USD 0.01 (0.45%)
Updated November 30, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 38.76M
Revenue (ttm) 4.84M
Net Income (ttm) -15.88M
Shares Out 17.23M
EPS (ttm) -1.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 30
Last Price $2.25
Previous Close $2.24
Change ($) 0.01
Change (%) 0.45%
Day's Open 2.23
Day's Range 2.16 - 2.27
Day's Volume 329,933
52-Week Range 0.58 - 7.00

More Stats

Market Cap 38.76M
Enterprise Value 38.15M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 17.23M
Float n/a
EPS (basic) -1.67
EPS (diluted) -1.47
FCF / Share -0.51
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.64M
Short Ratio 3.19
Short % of Float n/a
Beta 3.13
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 8.01
PB Ratio 2.76
Revenue 4.84M
Operating Income -11.17M
Net Income -15.88M
Free Cash Flow -8.20M
Net Cash 614,000
Net Cash / Share 0.04
Gross Margin 4.53%
Operating Margin -230.85%
Profit Margin -328.20%
FCF Margin -169.35%
ROA -27.70%
ROE -85.82%
ROIC 1,567.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$2.00*
Low
2.00
Current: $2.25
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3.132.861.722.691.931.2427.5431.4831.9720.05
Revenue Growth9.18%66.22%-36.02%39.61%55.56%-95.5%-12.5%-1.54%59.47%-
Gross Profit0.220.230.291.72-0.01-0.9410.7513.1318.449.76
Operating Income-10.99-13.91-15.51-0.74-8.92-10.57-15.76-9.50-2.97-3.61
Net Income-13.24-15.69-20.69-2.23-32.95-13.94-15.99-8.33-9.78-3.13
Shares Outstanding5.701.440.310.030.030.020.020.010.010.01
Earnings Per Share-2.33-13.82-107.40-141.59-1,251.06-904.55-1,035.05-697.54-1,179.06-324.03
Operating Cash Flow-9.14-6.75-6.69-0.96-12.38-13.70-8.47-10.200.22-1.72
Capital Expenditures-0.06-0.10-0.14--0.20-0.13-0.61-0.88-0.23-0.19
Free Cash Flow-9.20-6.85-6.83-0.96-12.58-13.83-9.08-11.09-0.01-1.91
Cash & Equivalents0.850.380.420.050.441.611.634.504.953.45
Total Debt1.365.113.585.437.607.846.566.1711.729.80
Net Cash / Debt-0.51-4.72-3.16-5.38-7.15-6.23-4.93-1.67-6.78-6.35
Assets19.5121.6127.260.844.8230.0130.2838.7933.5632.03
Liabilities6.3115.4814.247.3017.6423.4518.8318.5222.5122.07
Book Value13.216.1213.03-6.46-12.826.5511.4520.2711.058.50
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Precipio, Inc.
Country United States
Employees 50
CEO Ilan Danieli

Stock Information

Ticker Symbol PRPO
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: PRPO

Description

Precipio, a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Its product consists of clinical diagnostic services. The company's clinical diagnostic services focus on the diagnosis of different hematopoietic or blood-related cancers to oncologists. Its cytogenetics media IV-Cell enables laboratories to arrive at more accurate results; and HemeScreen panel enables hospitals and laboratories to run an important genetic mutation test. It serves oncologists, hospitals, reference laboratories, and pharma and biotech companies. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, such as the Yale School of Medicine and Harvard's Dana-Farber Cancer Institute. The company is based in New Haven, Connecticut.